#Table 1
Univariate coxph hosp_outcome 30 days
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.02 |
0.99, 1.04 |
0.162 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.56 |
0.31, 1.03 |
0.063 |
over 270days |
|
0.87 |
0.42, 1.80 |
0.699 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.69 |
0.39, 1.22 |
0.199 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.33 |
0.68, 2.58 |
0.406 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.34 |
0.80, 2.26 |
0.267 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.28 |
0.59, 2.81 |
0.530 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.11 |
0.67, 1.84 |
0.687 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.03 |
0.40, 2.65 |
0.954 |
subclass |
626 |
1.00 |
1.00, 1.01 |
0.419 |
Multivariate coxph hosp_outcome 30 days
days_last_vaccine_cat_new
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.02 |
0.99, 1.04 |
0.189 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.53 |
0.29, 0.97 |
0.041 |
over 270days |
|
0.76 |
0.36, 1.61 |
0.477 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.67 |
0.38, 1.19 |
0.173 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.16 |
0.58, 2.33 |
0.668 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.31 |
0.75, 2.26 |
0.343 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.10 |
0.47, 2.54 |
0.829 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.10 |
0.65, 1.87 |
0.722 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.82 |
0.29, 2.29 |
0.705 |
Multivariate coxph hosp_outcome 30 days
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.02 |
0.99, 1.04 |
0.189 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.53 |
0.29, 0.97 |
0.041 |
over 270days |
|
0.76 |
0.36, 1.61 |
0.477 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.67 |
0.38, 1.19 |
0.173 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.16 |
0.58, 2.33 |
0.668 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.31 |
0.75, 2.26 |
0.343 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.10 |
0.47, 2.54 |
0.829 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.10 |
0.65, 1.87 |
0.722 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.82 |
0.29, 2.29 |
0.705 |
Univariate coxph death 365 days
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.06 |
1.03, 1.09 |
<0.001 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.46 |
0.24, 0.89 |
0.021 |
over 270days |
|
0.61 |
0.24, 1.54 |
0.297 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.87 |
0.47, 1.61 |
0.661 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.04 |
0.51, 2.11 |
0.924 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.31 |
0.71, 2.39 |
0.388 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.04 |
0.57, 1.90 |
0.888 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.07 |
0.36, 3.18 |
0.906 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.90 |
0.91, 3.99 |
0.088 |
subclass |
626 |
1.01 |
1.00, 1.01 |
0.052 |
Multivariate coxph death 365 days
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.07 |
1.03, 1.10 |
<0.001 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.43 |
0.22, 0.86 |
0.017 |
over 270days |
|
0.46 |
0.17, 1.23 |
0.121 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.90 |
0.48, 1.68 |
0.744 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.69 |
0.30, 1.57 |
0.373 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.51 |
0.78, 2.91 |
0.223 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.72 |
0.82, 3.63 |
0.153 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.98 |
0.52, 1.85 |
0.948 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.77 |
0.28, 2.11 |
0.610 |
Univariate coxph new_renal_outcome
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
566 |
0.99 |
0.96, 1.02 |
0.440 |
days_last_vaccine_cat_new |
566 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
1.00 |
0.40, 2.47 |
0.996 |
over 270days |
|
0.47 |
0.09, 2.36 |
0.361 |
Gender_Legal_Sex |
566 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.76 |
0.36, 1.59 |
0.463 |
htn |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.30 |
0.50, 3.39 |
0.596 |
dm |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.88 |
0.86, 4.13 |
0.116 |
cad |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.32 |
0.61, 2.88 |
0.477 |
chf |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.38 |
0.35, 5.51 |
0.644 |
copd |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.34 |
0.05, 2.29 |
0.269 |
subclass |
566 |
1.00 |
0.99, 1.01 |
0.642 |
Multivariate coxph new_renal_outcome
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
566 |
0.99 |
0.95, 1.02 |
0.414 |
days_last_vaccine_cat_new |
566 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.94 |
0.38, 2.35 |
0.898 |
over 270days |
|
0.45 |
0.09, 2.27 |
0.335 |
Gender_Legal_Sex |
566 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.70 |
0.34, 1.43 |
0.325 |
htn |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.01 |
0.30, 3.38 |
0.989 |
dm |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.94 |
0.77, 4.90 |
0.162 |
cad |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.42 |
0.58, 3.49 |
0.445 |
chf |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.40 |
0.37, 5.31 |
0.624 |
copd |
566 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.27 |
0.04, 1.99 |
0.199 |
Univariate coxph new_dm_outcome
## Registered S3 method overwritten by 'gdata':
## method from
## reorder.factor DescTools
##
##
## Cell Contents
## |-------------------------|
## | N |
## | Chi-square contribution |
## | N / Row Total |
## | N / Col Total |
## | N / Table Total |
## |-------------------------|
##
##
## Total Observations in Table: 626
##
##
## | matched_final$days_last_vaccine_cat_new
## matched_final$new_dm_outcome_status | 0 | 0-270days | over 270days | Row Total |
## ------------------------------------|--------------|--------------|--------------|--------------|
## 0 | 153 | 373 | 91 | 617 |
## | 0.000 | 0.006 | 0.019 | |
## | 0.248 | 0.605 | 0.147 | 0.986 |
## | 0.987 | 0.982 | 1.000 | |
## | 0.244 | 0.596 | 0.145 | |
## ------------------------------------|--------------|--------------|--------------|--------------|
## 1 | 2 | 7 | 0 | 9 |
## | 0.023 | 0.432 | 1.308 | |
## | 0.222 | 0.778 | 0.000 | 0.014 |
## | 0.013 | 0.018 | 0.000 | |
## | 0.003 | 0.011 | 0.000 | |
## ------------------------------------|--------------|--------------|--------------|--------------|
## Column Total | 155 | 380 | 91 | 626 |
## | 0.248 | 0.607 | 0.145 | |
## ------------------------------------|--------------|--------------|--------------|--------------|
##
##
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
0.98 |
0.94, 1.01 |
0.221 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
1.43 |
0.29, 6.95 |
0.657 |
over 270days |
|
0.00 |
0.00, 0.00 |
<0.001 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.80 |
0.21, 3.01 |
0.745 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.51 |
0.41, 5.66 |
0.538 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
3.92 |
0.82, 18.8 |
0.087 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.00 |
0.00, 0.00 |
<0.001 |
subclass |
626 |
1.00 |
0.98, 1.01 |
0.415 |
Multivariate coxph new_dm_outcome
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
0.98 |
0.94, 1.01 |
0.212 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
1.48 |
0.32, 6.87 |
0.618 |
over 270days |
|
0.00 |
0.00, 0.00 |
<0.001 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.65 |
0.20, 2.11 |
0.479 |
cad |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.52 |
0.37, 6.16 |
0.561 |
chf |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
5.15 |
0.68, 39.2 |
0.114 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.00 |
0.00, 0.00 |
<0.001 |
Univariate Fine & Grey model new_cv_outcome
Characteristic |
N |
**Fine & Grey model new_cv_outcome **
|
HR |
95% CI |
p-value |
age_bl |
626 |
1.00 |
0.99, 1.02 |
0.560 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.86 |
0.56, 1.34 |
0.520 |
over 270days |
|
1.22 |
0.69, 2.18 |
0.500 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.05 |
0.73, 1.52 |
0.790 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.72 |
1.03, 2.88 |
0.038 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.11 |
1.44, 3.09 |
<0.001 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.98 |
0.52, 1.82 |
0.940 |
subclass |
626 |
1.00 |
1.00, 1.00 |
0.770 |
Multivariate Fine & Grey model new_cv_outcome
Characteristic |
N |
HR |
95% CI |
p-value |
age_bl |
626 |
1.00 |
0.99, 1.02 |
0.935 |
days_last_vaccine_cat_new |
626 |
|
|
|
0 |
|
— |
— |
|
0-270days |
|
0.80 |
0.51, 1.25 |
0.322 |
over 270days |
|
1.19 |
0.71, 1.98 |
0.513 |
Gender_Legal_Sex |
626 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.04 |
0.71, 1.53 |
0.839 |
htn |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.37 |
0.82, 2.28 |
0.225 |
dm |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.02 |
1.37, 2.98 |
<0.001 |
copd |
626 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.82 |
0.47, 1.43 |
0.491 |